Boots names joint broker

CSFB regains Reckitt Benckiser

Boots, the UK retailer which has put its healthcare business up for sale, announced today that it has appointed UBS as a joint corporate broker.

Boots, with a market capitalisation of £4.7bn (€6.9bn), appointed the Swiss bank alongside Merrill Lynch, which kept its mandate despite losing a team of brokers, led by Paul Baker, to Morgan Stanley last year.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump